FDC Faces Evaluation Shift Amid Declining Sales and Profit Performance

FDC, a midcap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in its evaluation. This revision reflects a shift in the stock's technical trends, which have transitioned from a sideways movement to a mildly bearish stance.
Key financial metrics indicate that FDC has faced challenges in its recent performance. The company reported a significant decline in its quarterly results for Q3 FY24-25, with net sales falling to Rs 464.11 crore, a decrease of 10.4% compared to the previous four-quarter average. Additionally, profit after tax (PAT) dropped to Rs 37.04 crore, marking a decline of 53.2% against the previous four-quarter average.

Over the past year, FDC's stock has generated a return of -2.85%, while profits have also seen a decrease of 5.3%. Despite a low debt-to-equity ratio, the company's long-term growth appears limited, with net sales growing at an annual rate of 10.15% and operating profit at 2.12% over the last five years.

Overall, the adjustment in evaluation reflects the underlying trends and events impacting FDC's market position and performance indicators.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.